These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9403262)

  • 21. Betadine for herpes simplex infection.
    Waters LJ; Barton SE; Boag FC
    Int J STD AIDS; 2006 Dec; 17(12):854-5. PubMed ID: 17212866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of treatment of herpes labialis with 1072 nm narrow waveband light.
    Dougal G; Kelly P
    Clin Exp Dermatol; 2001 Mar; 26(2):149-54. PubMed ID: 11298104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical comparison of two topical antiviral ointments in herpes].
    Makleit L; Nagy M
    Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment.
    Mofatteh MR; Naseripour Yazdi Z; Yousefi M; Namaei MH
    Braz J Otorhinolaryngol; 2018; 84(4):404-409. PubMed ID: 28549873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical pilot study of lignin--ascorbic acid combination treatment of herpes simplex virus.
    Lopez BS; Yamamoto M; Utsumi K; Aratsu C; Sakagami H
    In Vivo; 2009; 23(6):1011-6. PubMed ID: 20023248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
    Nguyen HP; Stiegel KR; Downing C; Stiegel KR
    Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of herpes genitalis.
    Singha HS; Nasr MS
    J Int Med Res; 1982; 10(1):39-41. PubMed ID: 7199494
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of T-actemodulin on herpes simplex virus infection.
    Varadinova T; Trashlieva M; Kemileva Z
    Acta Physiol Pharmacol Bulg; 1992; 18(2):33-40. PubMed ID: 1339076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of wound infection by 2-minute lavage with Betadine solution.
    Barr LL
    J Am Osteopath Assoc; 1978 Feb; 77(6):442-4. PubMed ID: 640878
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical trial of povidone-iodine (Betadine) versus placebo in the pretreatment of corneal ulcers.
    Gregori NZ; Schiffman JC; Miller DM; Alfonso EC
    Cornea; 2006 Jun; 25(5):558-63. PubMed ID: 16783144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control in chronic wound management: the role of local povidone-iodine (Betadine) therapy.
    Daróczy J
    Dermatology; 2006; 212 Suppl 1():82-7. PubMed ID: 16490980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis.
    Boivin G; Goyette N; Sergerie Y; Keays S; Booth T
    J Clin Virol; 2006 Dec; 37(4):248-51. PubMed ID: 17046320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients.
    da Silva LM; Guimarães AL; Victória JM; Gomes CC; Gomez RS
    Oral Dis; 2005 Jan; 11(1):13-6. PubMed ID: 15641961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics.
    Kawana R; Kitamura T; Nakagomi O; Matsumoto I; Arita M; Yoshihara N; Yanagi K; Yamada A; Morita O; Yoshida Y; Furuya Y; Chiba S
    Dermatology; 1997; 195 Suppl 2():29-35. PubMed ID: 9403252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial.
    Spruance SL; Stewart JC; Freeman DJ; Brightman VJ; Cox JL; Wenerstrom G; McKeough MB; Rowe NH
    J Infect Dis; 1990 Feb; 161(2):191-7. PubMed ID: 2153736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical and bacteriological study on povidone-iodine sugar ointment.
    Shiraishi T; Oka R; Nakagawa Y
    Dermatology; 1997; 195 Suppl 2():100-3. PubMed ID: 9403265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
    Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
    J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New successful treatment with disinfectant for atopic dermatitis.
    Sugimoto K; Kuroki H; Kanazawa M; Kurosaki T; Abe H; Takahashi Y; Ishiwada N; Nezu Y; Hoshioka A; Toba T
    Dermatology; 1997; 195 Suppl 2():62-8. PubMed ID: 9403258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.